These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 35459392)

  • 1. [Introduction: Patients with primary adrenal insufficiency receive long - term glucocorticoid replacement therapy, which may cause osteoporosis].
    Vaňuga P; Ságová I
    Vnitr Lek; 2021; 67(5):264-269. PubMed ID: 35459392
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bone mineral density is not significantly reduced in adult patients on low-dose glucocorticoid replacement therapy.
    Koetz KR; Ventz M; Diederich S; Quinkler M
    J Clin Endocrinol Metab; 2012 Jan; 97(1):85-92. PubMed ID: 21994966
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Increased serum osteoprotegerin in patients with primary adrenal insufficiency receiving conventional hydrocortisone substitution.
    Fichna M; Zurawek M; Fichna P; Gryczynska M; Nowak J; Ruchala M
    J Physiol Pharmacol; 2012 Dec; 63(6):677-82. PubMed ID: 23388484
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bone density and turnover in Addison's disease: effect of glucocorticoid treatment.
    Valero MA; Leon M; Ruiz Valdepeñas MP; Larrodera L; Lopez MB; Papapietro K; Jara A; Hawkins F
    Bone Miner; 1994 Jul; 26(1):9-17. PubMed ID: 7950508
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of glucocorticoid replacement therapy on bone mineral density in patients with Addison disease.
    Zelissen PM; Croughs RJ; van Rijk PP; Raymakers JA
    Ann Intern Med; 1994 Feb; 120(3):207-10. PubMed ID: 8273983
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Metabolic assessment of hydrocortisone replacement therapy in patients with primary adrenocortical insufficiency].
    Fichna M; Gryczyńska M; Sowińska A; Sowiński J
    Przegl Lek; 2011; 68(2):96-102. PubMed ID: 21751518
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vertebral fractures assessed with dual-energy X-ray absorptiometry in patients with Addison's disease on glucocorticoid and mineralocorticoid replacement therapy.
    Camozzi V; Betterle C; Frigo AC; Zaccariotto V; Zaninotto M; De Caneva E; Lucato P; Gomiero W; Garelli S; Sabbadin C; Salvà M; Costa MD; Boscaro M; Luisetto G
    Endocrine; 2018 Feb; 59(2):319-329. PubMed ID: 28795340
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-term follow-up of bone mineral density in Addison's disease.
    Jódar E; Valdepeñas MP; Martinez G; Jara A; Hawkins F
    Clin Endocrinol (Oxf); 2003 May; 58(5):617-20. PubMed ID: 12699444
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reduction in daily hydrocortisone dose improves bone health in primary adrenal insufficiency.
    Schulz J; Frey KR; Cooper MS; Zopf K; Ventz M; Diederich S; Quinkler M
    Eur J Endocrinol; 2016 Apr; 174(4):531-8. PubMed ID: 26811406
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An assessment of bone mineral density in patients with Addison's disease and isolated ACTH deficiency treated with glucocorticoid.
    Chikada N; Imaki T; Hotta M; Sato K; Takano K
    Endocr J; 2004 Jun; 51(3):355-60. PubMed ID: 15256782
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Glucocorticoid replacement therapy and pharmacogenetics in Addison's disease: effects on bone.
    Løvås K; Gjesdal CG; Christensen M; Wolff AB; Almås B; Svartberg J; Fougner KJ; Syversen U; Bollerslev J; Falch JA; Hunt PJ; Chatterjee VK; Husebye ES
    Eur J Endocrinol; 2009 Jun; 160(6):993-1002. PubMed ID: 19282465
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of hydrocortisone replacement on bone mineral density and bone turnover markers in patients with primary adrenal insufficiency.
    Yazidi M; Danguir C; Maamer D; Oueslati I; Khiari K; Elleuch M; Feki M; Chihaoui M
    Endocr Regul; 2022 Jul; 56(3):209-215. PubMed ID: 35843715
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bone mineral density is reduced in female but not male subjects with Addison's disease.
    Florkowski CM; Holmes SJ; Elliot JR; Donald RA; Espiner EA
    N Z Med J; 1994 Feb; 107(972):52-3. PubMed ID: 8115069
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Low bone mineral density for age/osteoporosis in triple A syndrome-an overlooked symptom of unexplained etiology.
    Dumic M; Putarek NR; Kusec V; Barisic N; Koehler K; Huebner A
    Osteoporos Int; 2016 Feb; 27(2):521-6. PubMed ID: 26243364
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Successful treatment of high turnover osteoporosis in a patient with adrenocortical insufficiency.
    Aringer M; Vierhapper H; Graninger MT; Bernecker P; Smolen JS; Pietschmann P
    Wien Klin Wochenschr; 2000 Apr; 112(7):334-7. PubMed ID: 10849958
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of DHEA supplementation on serum IGF-1, osteocalcin, and bone mineral density in postmenopausal, glucocorticoid-treated women.
    Papierska L; Rabijewski M; Kasperlik-Załuska A; Zgliczyński W
    Adv Med Sci; 2012 Jun; 57(1):51-7. PubMed ID: 22430044
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Primary prevention of glucocorticoid-induced osteoporosis with intravenous pamidronate and calcium: a prospective controlled 1-year study comparing a single infusion, an infusion given once every 3 months, and calcium alone.
    Boutsen Y; Jamart J; Esselinckx W; Devogelaer JP
    J Bone Miner Res; 2001 Jan; 16(1):104-12. PubMed ID: 11149473
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bone mineral density in patients with treated Addison's disease.
    Braatvedt GD; Joyce M; Evans M; Clearwater J; Reid IR
    Osteoporos Int; 1999; 10(6):435-40. PubMed ID: 10663342
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bone loss is more severe in primary adrenal than in pituitary-dependent Cushing's syndrome.
    Minetto M; Reimondo G; Osella G; Ventura M; Angeli A; Terzolo M
    Osteoporos Int; 2004 Nov; 15(11):855-61. PubMed ID: 15034643
    [TBL] [Abstract][Full Text] [Related]  

  • 20. BONE MINERAL DENSITY IN PATIENTS WITH ADDISON DISEASE ON REPLACEMENT THERAPY WITH PREDNISOLONE.
    Chandy DD; Bhatia E
    Endocr Pract; 2016 Apr; 22(4):434-9. PubMed ID: 26684152
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.